Company Profile

L2 Diagnostics LLC (AKA: L-Two Diagnostics LLC)
Profile last edited on: 2/10/2020      CAGE: 43BA5      UEI: GKA7VH5LFR25

Business Identifier: Candidate biomarkers in diagnosis of Lyme disease, ETBF, and diabetes.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

300 George Street Unit 309
New Haven, CT 06511
   (203) 494-5288
Location: Single
Congr. District: 03
County: New Haven

Public Profile

L2 Diagnostics is a private biotechnology firm spinoff from The Yale School of Medicine Lyme/Lupus Diagnostics Laboratory. L2 Diagnostics is developing new diagnostic methods that will help distinguish patients infected with Lyme disease from those who have been vaccinated. The firm has broadened its scope of R&D into disease biomarkers and therapies. The firm is identified as working to develop diagnostics and therapeutics and to be located Department of Internal Medicine, Yale School of Medicine

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Martin J Mattessich -- President

  Karen G Anthony

  Linda Bockenstedt

  Nathalie Marie Bonafe

  Michael Cappello

  Erol Fikrig

  Kevan C Herold

  Raymond Morris Johnson

  Barbara I Kazmierczak

  Raymond A Koski

  Michel E Ledizet

  Mark J Mamula

  Yorgo Modis

  Saraspadee Mootien

  Saraspadee Mootien

  Sukanya Narasimhan

  Elizabeth Peterson-Roth

  Diane Mcmahon Pratt

  Elizabeth P Roth

  Alan Sutherland

  Sahar Usmani-Brown

  Sahar Usmanibrown

  Narendra Wajapeyee

  Jason Weinstein

  Adam Wisnewski